Who owns Faeth Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of FTH from SEC Form 13F filings across 45 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 45 institutions disclosed 14.1M shares of Faeth Therapeutics, Inc. worth $333.8M — about 249.4% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
45
13F holders
$333.8M
value, 2026 filers
249.4%
of shares outstanding (14.1M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of FTH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 2.0M | $50.5M | 0.9% | 35.8% | +5747.1% |
| 2 | Avoro Capital Advisors LLCNEW | 1.4M | $36.1M | 0.3% | 25.6% | new |
| 3 | BAKER BROS. ADVISORS LPNEW | 1.3M | $32.2M | 0.2% | 22.8% | new |
| 4 | Balyasny Asset Management L.P. | 1.0M | $26.1M | 0.0% | 18.5% | +6331.3% |
| 5 | Cormorant Asset Management, LP | 1.0M | $7.7M | 0.4% | 18.2% | +235.8% |
| 6 | Logos Global Management LP | 722,020 | $18.1M | 0.8% | 12.8% | +2306.7% |
| 7 | Vivo Capital, LLC | 722,020 | $18.1M | 1.6% | 12.8% | 0.0% |
| 8 | Fairmount Funds Management LLCNEW | 722,020 | $18.1M | 1.2% | 12.8% | new |
| 9 | RA CAPITAL MANAGEMENT, L.P.NEW | 722,020 | $18.1M | 0.2% | 12.8% | new |
| 10 | Caligan Partners LP | 629,467 | $15.7M | 0.7% | 11.2% | +399.6% |
| 11 | B Group, Inc.NEW | 610,169 | $15.3M | 7.2% | 10.8% | new |
| 12 | Trails Edge Capital Partners, LP | 515,335 | $12.9M | 2.0% | 9.1% | +312.3% |
| 13 | FRANKLIN RESOURCES INC | 494,516 | $12.4M | 0.0% | 8.8% | +270.4% |
| 14 | Octagon Capital Advisors LPNEW | 361,010 | $9.0M | 0.8% | 6.4% | new |
| 15 | ADAR1 Capital Management, LLCNEW | 361,010 | $9.0M | 0.4% | 6.4% | new |
| 16 | MARSHALL WACE, LLP | 206,508 | $5.2M | 0.0% | 3.7% | +214.2% |
| 17 | Boxer Capital Management, LLCNEW | 180,505 | $4.5M | 0.3% | 3.2% | new |
| 18 | Patient Square Capital LPNEW | 175,050 | $4.4M | 0.7% | 3.1% | new |
| 19 | Affinity Asset Advisors, LLCNEW | 144,404 | $3.6M | 0.2% | 2.6% | new |
| 20 | Alyeska Investment Group, L.P.NEW | 144,404 | $3.6M | 0.0% | 2.6% | new |
| 21 | BOOTHBAY FUND MANAGEMENT, LLC | 133,643 | $3.3M | 0.0% | 2.4% | +411.6% |
| 22 | AWM Investment Company, Inc.NEW | 111,343 | $2.8M | 0.2% | 2% | new |
| 23 | Richmond Investment Services, LLCNEW | 79,731 | $2.0M | 0.6% | 1.4% | new |
| 24 | Ikarian Capital, LLC | 35,386 | $884,650 | 0.1% | 0.6% | +457.2% |
| 25 | UBS Group AG | 21,541 | $538,525 | 0.0% | 0.4% | +375.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.